Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1200 participants.

Also called NCT05650541

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 1,200 participants (planned count) (from the registry)
Sponsor
Analog Device, Inc. (from the registry)
Registry
  • NCT NCT05650541
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05650541. Randomized; single masking; primary purpose prevention. Start 2023-09-22 (actual); primary completion 2026-12-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
Acronym
BETA
Condition
Heart Failure
Intervention (Device)
CardioPumlonary Management System
Lead sponsor
Analog Device, Inc. (class: other)

Record details

Record id
cardio:ct-nct05650541
Content hash
84b5e6564a9a1e4419dc8b45d8f46117324efd91c2b23033ac11186ad4b044d0